Global Insulin Glargine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030

Global Insulin Glargine Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030


Summary

nsulin glargine, marketed under the names Lantus among others, is a long-acting basal insulin analogue, given once daily to help control the blood sugar level of those with diabetes. It consists of microcrystals that slowly release insulin, giving a long duration of action of 18 to 26 hours, with a peakless profile (according to the insulin glargine package insert).

According to APO Research, The global Insulin Glargine market is projected to grow from US$ million in 2024 to US$ million by 2030, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

North American market for Insulin Glargine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Asia-Pacific market for Insulin Glargine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The China market for Insulin Glargine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

Europe market for Insulin Glargine is estimated to increase from $ million in 2024 to reach $ million by 2030, at a CAGR of % during the forecast period of 2025 through 2030.

The major global manufacturers of Insulin Glargine include Sanofi-Aventis, Ganlee and Biocon, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Insulin Glargine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2019 - 2023, estimates for 2024, and projections of CAGR through 2030.

This report researches the key producers of Insulin Glargine, also provides the sales of main regions and countries. Of the upcoming market potential for Insulin Glargine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Insulin Glargine sales, revenue, market share and industry ranking of main manufacturers, data from 2019 to 2024. Identification of the major stakeholders in the global Insulin Glargine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2019 to 2030. Evaluation and forecast the market size for Insulin Glargine sales, projected growth trends, production technology, application and end-user industry.

Insulin Glargine segment by Company

Sanofi-Aventis
Ganlee
Biocon
Insulin Glargine segment by Type

Single Dose Vial
Pre-filled Syringe
Insulin Glargine segment by Application

Treat Type2 Diabetes
Treat Type1 Diabetes
Insulin Glargine segment by Region

North America
U.S.
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

Study Objectives

1. To analyze and research the global Insulin Glargine status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions Insulin Glargine market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify Insulin Glargine significant trends, drivers, influence factors in global and regions.
6. To analyze Insulin Glargine competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Insulin Glargine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Insulin Glargine and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Insulin Glargine.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Insulin Glargine market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2019-2030).
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Insulin Glargine industry.
Chapter 3: Detailed analysis of Insulin Glargine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales and value of Insulin Glargine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.
Chapter 7: Sales and value of Insulin Glargine in country level. It provides sigmate data by type, and by application for each country/region.
Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Concluding Insights.


1 Market Overview
1.1 Product Definition
1.2 Global Market Growth Prospects
1.2.1 Global Insulin Glargine Sales Value (2019-2030)
1.2.2 Global Insulin Glargine Sales Volume (2019-2030)
1.2.3 Global Insulin Glargine Sales Average Price (2019-2030)
1.3 Assumptions and Limitations
1.4 Study Goals and Objectives
2 Insulin Glargine Market Dynamics
2.1 Insulin Glargine Industry Trends
2.2 Insulin Glargine Industry Drivers
2.3 Insulin Glargine Industry Opportunities and Challenges
2.4 Insulin Glargine Industry Restraints
3 Insulin Glargine Market by Company
3.1 Global Insulin Glargine Company Revenue Ranking in 2023
3.2 Global Insulin Glargine Revenue by Company (2019-2024)
3.3 Global Insulin Glargine Sales Volume by Company (2019-2024)
3.4 Global Insulin Glargine Average Price by Company (2019-2024)
3.5 Global Insulin Glargine Company Ranking, 2022 VS 2023 VS 2024
3.6 Global Insulin Glargine Company Manufacturing Base & Headquarters
3.7 Global Insulin Glargine Company, Product Type & Application
3.8 Global Insulin Glargine Company Commercialization Time
3.9 Market Competitive Analysis
3.9.1 Global Insulin Glargine Market CR5 and HHI
3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2023
3.9.3 2023 Insulin Glargine Tier 1, Tier 2, and Tier
3.10 Mergers & Acquisitions, Expansion
4 Insulin Glargine Market by Type
4.1 Insulin Glargine Type Introduction
4.1.1 Single Dose Vial
4.1.2 Pre-filled Syringe
4.2 Global Insulin Glargine Sales Volume by Type
4.2.1 Global Insulin Glargine Sales Volume by Type (2019 VS 2023 VS 2030)
4.2.2 Global Insulin Glargine Sales Volume by Type (2019-2030)
4.2.3 Global Insulin Glargine Sales Volume Share by Type (2019-2030)
4.3 Global Insulin Glargine Sales Value by Type
4.3.1 Global Insulin Glargine Sales Value by Type (2019 VS 2023 VS 2030)
4.3.2 Global Insulin Glargine Sales Value by Type (2019-2030)
4.3.3 Global Insulin Glargine Sales Value Share by Type (2019-2030)
5 Insulin Glargine Market by Application
5.1 Insulin Glargine Application Introduction
5.1.1 Treat Type2 Diabetes
5.1.2 Treat Type1 Diabetes
5.2 Global Insulin Glargine Sales Volume by Application
5.2.1 Global Insulin Glargine Sales Volume by Application (2019 VS 2023 VS 2030)
5.2.2 Global Insulin Glargine Sales Volume by Application (2019-2030)
5.2.3 Global Insulin Glargine Sales Volume Share by Application (2019-2030)
5.3 Global Insulin Glargine Sales Value by Application
5.3.1 Global Insulin Glargine Sales Value by Application (2019 VS 2023 VS 2030)
5.3.2 Global Insulin Glargine Sales Value by Application (2019-2030)
5.3.3 Global Insulin Glargine Sales Value Share by Application (2019-2030)
6 Insulin Glargine Market by Region
6.1 Global Insulin Glargine Sales by Region: 2019 VS 2023 VS 2030
6.2 Global Insulin Glargine Sales by Region (2019-2030)
6.2.1 Global Insulin Glargine Sales by Region: 2019-2024
6.2.2 Global Insulin Glargine Sales by Region (2025-2030)
6.3 Global Insulin Glargine Sales Value by Region: 2019 VS 2023 VS 2030
6.4 Global Insulin Glargine Sales Value by Region (2019-2030)
6.4.1 Global Insulin Glargine Sales Value by Region: 2019-2024
6.4.2 Global Insulin Glargine Sales Value by Region (2025-2030)
6.5 Global Insulin Glargine Market Price Analysis by Region (2019-2024)
6.6 North America
6.6.1 North America Insulin Glargine Sales Value (2019-2030)
6.6.2 North America Insulin Glargine Sales Value Share by Country, 2023 VS 2030
6.7 Europe
6.7.1 Europe Insulin Glargine Sales Value (2019-2030)
6.7.2 Europe Insulin Glargine Sales Value Share by Country, 2023 VS 2030
6.8 Asia-Pacific
6.8.1 Asia-Pacific Insulin Glargine Sales Value (2019-2030)
6.8.2 Asia-Pacific Insulin Glargine Sales Value Share by Country, 2023 VS 2030
6.9 Latin America
6.9.1 Latin America Insulin Glargine Sales Value (2019-2030)
6.9.2 Latin America Insulin Glargine Sales Value Share by Country, 2023 VS 2030
6.10 Middle East & Africa
6.10.1 Middle East & Africa Insulin Glargine Sales Value (2019-2030)
6.10.2 Middle East & Africa Insulin Glargine Sales Value Share by Country, 2023 VS 2030
7 Insulin Glargine Market by Country
7.1 Global Insulin Glargine Sales by Country: 2019 VS 2023 VS 2030
7.2 Global Insulin Glargine Sales Value by Country: 2019 VS 2023 VS 2030
7.3 Global Insulin Glargine Sales by Country (2019-2030)
7.3.1 Global Insulin Glargine Sales by Country (2019-2024)
7.3.2 Global Insulin Glargine Sales by Country (2025-2030)
7.4 Global Insulin Glargine Sales Value by Country (2019-2030)
7.4.1 Global Insulin Glargine Sales Value by Country (2019-2024)
7.4.2 Global Insulin Glargine Sales Value by Country (2025-2030)
7.5 USA
7.5.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.5.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.5.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.6 Canada
7.6.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.6.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.6.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.7 Germany
7.7.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.7.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.7.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.8 France
7.8.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.8.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.8.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.9 U.K.
7.9.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.9.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.9.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.10 Italy
7.10.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.10.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.10.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.11 Netherlands
7.11.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.11.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.11.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.12 Nordic Countries
7.12.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.12.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.12.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.13 China
7.13.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.13.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.13.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.14 Japan
7.14.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.14.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.14.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.15 South Korea
7.15.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.15.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.15.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.16 Southeast Asia
7.16.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.16.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.16.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.17 India
7.17.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.17.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.17.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.18 Australia
7.18.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.18.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.18.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.19 Mexico
7.19.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.19.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.19.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.20 Brazil
7.20.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.20.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.20.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.21 Turkey
7.21.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.21.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.21.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.22 Saudi Arabia
7.22.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.22.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.22.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
7.23 UAE
7.23.1 Global Insulin Glargine Sales Value Growth Rate (2019-2030)
7.23.2 Global Insulin Glargine Sales Value Share by Type, 2023 VS 2030
7.23.3 Global Insulin Glargine Sales Value Share by Application, 2023 VS 2030
8 Company Profiles
8.1 Sanofi-Aventis
8.1.1 Sanofi-Aventis Comapny Information
8.1.2 Sanofi-Aventis Business Overview
8.1.3 Sanofi-Aventis Insulin Glargine Sales, Value and Gross Margin (2019-2024)
8.1.4 Sanofi-Aventis Insulin Glargine Product Portfolio
8.1.5 Sanofi-Aventis Recent Developments
8.2 Ganlee
8.2.1 Ganlee Comapny Information
8.2.2 Ganlee Business Overview
8.2.3 Ganlee Insulin Glargine Sales, Value and Gross Margin (2019-2024)
8.2.4 Ganlee Insulin Glargine Product Portfolio
8.2.5 Ganlee Recent Developments
8.3 Biocon
8.3.1 Biocon Comapny Information
8.3.2 Biocon Business Overview
8.3.3 Biocon Insulin Glargine Sales, Value and Gross Margin (2019-2024)
8.3.4 Biocon Insulin Glargine Product Portfolio
8.3.5 Biocon Recent Developments
9 Value Chain and Sales Channels Analysis
9.1 Insulin Glargine Value Chain Analysis
9.1.1 Insulin Glargine Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 Manufacturing Cost Structure
9.1.4 Insulin Glargine Sales Mode & Process
9.2 Insulin Glargine Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 Insulin Glargine Distributors
9.2.3 Insulin Glargine Customers
10 Concluding Insights
11 Appendix
11.1 Reasons for Doing This Study
11.2 Research Methodology
11.3 Research Process
11.4 Authors List of This Report
11.5 Data Source
11.5.1 Secondary Sources
11.5.2 Primary Sources

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings